Trial Profile
Open-label, single-arm, multi-center validation study of the ROSA-Scale (Relevant Outcome Scale for Alzheimer Patients) in patients with dementia of Alzheimer's type (DAT) treated with memantine over a 3 months period
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Dec 2012
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Merz Pharmaceuticals GmbH
- 23 Dec 2012 New trial record